baber/WOPTO huggingface dataset:
Patent EP-2996827-A1 (EP)
Inventor: RUPOLI SIMONE
IPC: B21F27/12
Filed: 2014-05-19
Abstract: The apparatus for making metal cages (2) for conical pillars, the cages being made by a series of longitudinal bars (3), arranged according to a predetermined circular geometrical shape about a longitudinal axis (A), and fixed through the fixing of at least one metal wire (4), wound in spiral on the same bars (3) through the combination of a rotation motion about an axis coinciding with the longitudinal axis (A) of the cage (2) being manufactured and a shifting motion, comprises a first support head (10) suitable to support respective further portions of the bars (3), a second support head (20) suitable to support respective further portions of the bars (3), a radial handling unit (30), suitable to carry out the controlled radial displacement of the supported bars (3), so as to allow the progressive positioning of the bars (3) according to a shape convergent towards the longitudinal axis (A) and therefore the manufacturing of the conical metal cage.
Patent EP-3019014-A1 (EP)
Inventor: MUENKS KARL-WILHELM
IPC: A01N63/22
Filed: 2014-07-10
Abstract: The present invention relates to the use of a combination comprising at least one host defense inducer and at least one biological control agent in a synergistically effective amount for controlling bacterial harmful organisms in useful plants. The biological control agent is selected from specific microorganisms and/or a mutant of these strains having all the identifying characteristics of the respective strain, and/or a metabolite produced by the respective strain. In a preferred aspect of the invention the host defense inducer is isotianil or a combination of isotianil and acibenzolar-S-methyl. The present invention also relates to a method for controlling bacterial harmful organisms in useful plants by treatment with a combination comprising at least one host defense inducer and at least one biological control agent in a synergistically effective amount. A further aspect of the present invention is directed to method for controlling bacterial harmful organisms in useful plants by subjecting the plants to be protected against attack by bacterial harmful organisms to two or more sequential treatment blocks.
Patent EP-3019573-A1 (EP)
Inventor: PFEIL ARMIN
IPC: C09J133/00
Filed: 2014-07-09
Abstract: L'invention concerne une composition de résine de réaction comprenant un constituant résine qui contient un composé radicalement polymérisable, et un système initiateur qui contient un ester carboxylique α-halogéné et un système catalyseur qui contient un sel de cuivre(l) et au moins un ligand azoté. L'invention concerne également son utilisation à des fins de construction.
Patent EP-3022053-A1 (EP)
Title: Mehrlagiges verbundmaterial und gegenstände daraus
Inventor: LÜHN HOLGER
IPC: B32B5/16
Filed: 2014-07-11
Abstract: Die vorliegende Erfindung betrifft ein mehrlagiges Verbundmaterial mit Barriereeigenschaften, Gegenstände, insbesondere Kraftstoffbehälter, umfassend dasselbe, Verfahren zur Herstellung des mehrlagigen Verbundmaterials bzw. der Gegenstände, die selbiges umfassen sowie die Verwendung des mehrlagigen Verbundmaterials bzw. der Gegenstände zur Verminderung der Emission von flüchtigen organischen Verbindungen.
Patent EP-3024385-A1 (EP)
Inventor: GHOSH SUBHAM
IPC: A61B5/366
Filed: 2014-07-22
Abstract: A medical device system performs a method determining presence of scar tissue. Torso-surface potential signals are received by a processor from multiple electrodes distributed on a torso of a patient. The processor extracts features of the potential signal from each electrode and stores values of the features in a non-transitory storage medium. The processor determines a scar indicator index for each of the electrodes from the stored features and identifies which ones of the electrodes have an affirmative scar indicator index. An overall scar burden index is determined as a proportion of the electrodes with an affirmative scar indicator index.
Patent EP-3035961-A1 (EP)
Inventor: SCHNEE MARGIT
IPC: A61K39/205
Filed: 2014-08-21
Abstract: The present invention relates to an mRNA sequence, comprising a coding region, encoding at least one antigenic peptide or protein of Rabies virus or a fragment, variant or derivative thereof. Additionally the present invention relates to a composition comprising a plurality of mRNA sequences comprising a coding region, encoding at least one antigenic peptide or protein of Rabies virus or a fragment, variant or derivative thereof. Furthermore it also discloses the use of the mRNA sequence or the composition comprising a plurality of mRNA sequences for the preparation of a pharmaceutical composition, especially a vaccine, e.g. for use in the prophylaxis or treatment of Rabies virus infections. The present invention further describes a method of treatment or prophylaxis of rabies using the mRNA sequence.
Patent EP-2983993-A1 (EP)
Inventor: PERAZZO NICHOLAS J
IPC: B65B3/04
Filed: 2014-03-07
Abstract: A fully-automated system (1 ) suitable for use in a hospital setting for filling patient- specific liquid prescriptions to be administered by oral syringes on a just-in-time basis. The system enables hospital pharmacists to simplify and streamline their task, increasing the number of prescriptions that can be filled in a day, improving patient safety and care by minimizing medication errors and the consequences that ensue.
Patent EP-2974377-A1 (EP)
Inventor: ANDERSSON MARCUS
IPC: H04R13/00
Filed: 2014-03-14
Abstract: La présente invention concerne un dispositif qui comprend un transducteur électromagnétique comportant un corps de bobine renfermant un espace, un appareil de connexion ayant une relation fixe avec le corps de bobine configuré pour transférer de l'énergie vibratoire directement ou indirectement en direction et/ou en provenance du transducteur électromagnétique, et un passage allant de l'espace à l'appareil de connexion.
Patent EP-2974723-A1 (EP)
Inventor: LIN SHINN-ZONG
IPC: A61K31/365
Filed: 2014-02-13
Abstract: An application of a phthalide compound in preparing a medicament. The medicament is specially used for promoting a stem cell to secrete one of the following items: telomerase, a neurotrophic factor (brain-derived neurotrophic factor, BDNF), a stem cell chemotactic factor (stromal cell-derived factor-1, SDF1), a stem cell chemotactic factor receptor (CXC chemokine receptor 4, CXCR4), and an immunoregulatory factor; a kit comprising a phthalide compound and a stem cell is also provided.
Patent EP-3049809-A1 (EP)
Inventor: BAUDOUIN CAROLINE
IPC: G01N33/68
Filed: 2014-09-24
Abstract: The invention relates to  in vitro  methods for testing formulations or active ingredients for preventing the harmful effects of UV on children's skin, in particular children aged three or less. The inventors have developed methods for evaluating the  in vitro  efficacy of formulations in preventing the harmful effects of UV on the skin of children aged three or less, using a skin model specifically capable of reproducing the characteristics of the skin of children of this age.
Patent EP-2983932-A1 (EP)
Inventor: TANG GUO
IPC: F16H57/028
Filed: 2014-03-27
Abstract: An integrated hybrid power assembly and a vehicle are provided. The integrated hybrid power assembly includes a transmission(100) comprising a front housing(120)and a rear housing (110); a drive motor(200) comprising a motor housing(210) integral to the rear housing(110) and a motor cover(220) mounted to the motor housing(210); a speed reducer(300) comprising a reducer housing(310) which is connected to the rear housing(110) and integral to the motor cover (220), and a reducer cover(320) mounted to the reducer housing(310); and a starting motor(400) mounted to the transmission(100).
Patent EP-2973685-A1 (EP)
Inventor: SAMARAO ASHWIN
IPC: H01L23/12
Filed: 2014-03-13
Abstract: La présente invention concerne un dispositif de microsystème électromécanique (MEMS) comprenant un piège à gaz haute densité. Le piège à gaz haute densité comprend une surface de silicium formée par formation de porosités ou par formation de tranchées dans une cavité étanche du dispositif. La surface de silicium comprend un dépôt de titane ou d'autre matériau de piégeage afin de réduire la quantité de gaz présente dans la chambre étanche de façon à former une chambre basse pression. Le piège à gaz haute densité est utilisé dans des bolomètres et dans des gyroscopes, mais ne se limite pas à ces dispositifs.
Patent EP-3053244-A1 (EP)
Inventor: FLEURY BENOIT
IPC: H02J7/34
Filed: 2014-09-30
Abstract: The invention relates to a device (10) for the electric power supply of a load (11), comprising at least two energy storage elements (13, 14), means for determining the power needs of said load (11), means (16, 17) for monitoring each energy storage element (13, 14), which are able to provide information about a maximum instantaneous power of each energy storage element (13, 14), a calculation body (19) for determining a maximum secured power according to the electromotive force (Ebat(t)) and the resistance (Rbat(t)) of the Thévenin model, a maximum specified current and a maximum specified voltage, and means (Cbat(t), Csc(t)) for controlling each energy storage element (13, 14), said means being adjusted over time according to the power needs of said load (11) and the maximum secured power of each energy storage element (13, 14).
Patent EP-3024514-A1 (EP)
Inventor: BERTOLI ALESSANDRO
IPC: A61M5/158
Filed: 2014-07-21
Abstract: The butterfly needle (1 ) with a protective device (2) comprises: a central body (3) having a proximal end (3A) and an opposite distal end (3B); a pair of wings (4) bilaterally extending from said central body (3); a safety device (2) designed to be automatically actuated by traction; a needle (10) with a shank (10') having engaging means (20) near its tip (19) for engagement with with said safety device (2) and which is supported by a needle hub (9) at an opposite proximal end, said needle (10) being slidingly longitudinally received in said central body (3), which comprises an inner housing chamber (13) between said proximal end (3A) and said distal end (3B), and wherein said safety device (2) is irreversibly slidingly housed between a rest position and an actuated position.
Patent EP-3053187-A1 (EP)
Inventor: MEI CHONG
IPC: H01P11/00
Filed: 2014-09-30
Abstract: The present invention is directed to an RF device that includes a ceramic layer characterized by a ceramic layer dielectric constant and includes an RF circuit arrangement having a predetermined geometry and predetermined electrical characteristics. The ceramic layer dissipates thermal energy generated by the RF circuit via substantially the entire ceramic surface area. A first dielectric layer comprises a thermoplastic material and has a predetermined first thickness and a first dielectric constant. The predetermined electrical characteristics of the RF circuit arrangement are a function of the ceramic layer dielectric constant. A relative softness of the thermoplastic material is a function of the RF device operating temperature.
Patent EP-2987470-A1 (EP)
Inventor: YAMAUCHI KIYOSHI
IPC: A61L31/14
Filed: 2014-04-15
Abstract: Provided are a stent which has sufficient strength, is easily reduced in diameter to facilitate insertion of the stent into a tube, and can be smoothly expanded from inside the tube and a process for producing the stent. This stent (10) is a self-expandable stent constituted of an Ni-Ti base alloy or Co-Cr base alloy and formed into a cylindrical shape with mesh openings. The stent has been configured so that the Af point is 22-26°C, the stress-displacement curve has a yield point, and the crystal grains in a cross-section of the stent have an average cross-sectional area, as determined by the area fraction method, of 0.2-50 µm 2 . The stent can be produced by inserting a core bar (22) into a cylindrical stent base (20), forming mesh openings with laser light, subsequently removing the core bar from the stent base, expanding the stent base to a given diameter in an atmosphere having a temperature of 350°C or lower, and then subjecting the expanded stent base to a heat treatment at 400-600°C for 5-60 minutes to regulate the Af point to 22 to 26°C.
Patent EP-2986623-A1 (EP)
Title: 19-nor-c21-n-pyrazolyl-stéroïdes c3,3-disubstitués et procédés d'utilisation de ceux-ci
Inventor: BOTELLA GABRIEL MARTINEZ
IPC: A61K31/58
Filed: 2014-04-17
Abstract: La présente invention concerne des 19-nor-C21-pyrazolyl-stéroïdes C3,3-disubstitués de formule (I), et des sels pharmaceutiquement acceptables de ceux-ci ; où R 1 , R 2 , R 3a , R 3b , R 4a , R 4b , R 5 , R 6 , et R 7  sont tels que définis dans la description. De tels composés sont envisagés comme étant utiles pour la prévention et le traitement de différentes affections associées au SNC, par exemple le traitement de troubles du sommeil, troubles de l'humeur, troubles du spectre de la schizophrénie, troubles convulsifs, troubles de la mémoire et/ou de la cognition, troubles moteurs, troubles de la personnalité, troubles du spectre de l'autisme, douleur, traumatisme crânien, maladies vasculaires, troubles de toxicomanie et/ou syndromes de sevrage, et acouphènes.
Patent EP-3060588-A1 (EP)
Inventor: GADDI BENEDETTA
IPC: C08F10/06
Filed: 2014-10-21
Abstract: Process for the preparation of a porous propylene carried out in the presence of a catalyst system comprising (a) a Ziegler-Natta catalyst containing at least two electron donor compounds one of which being present in an amount from 50 to 90% by mol with respect to the total amount of donors and selected from succinates and the other being selected from 1,3 diethers, (b) an aluminum alkyl and comprising the following steps: i) contacting the catalyst components (a) and (b) for a period of time ranging from 1 to 60 minutes, at a temperature ranging from 35 to 55°C; optionally, ii) pre-polymerizing with one or more olefins of formula CH 2 =CHR, where R is H or a C 1 -C 10  hydrocarbon group, up to forming amounts of polymer from about 0.1 up to about 1000 g per gram of solid catalyst component (a); and iii) polymerizing propylene in the optional presence of minor amounts of ethylene and/or C 4 -C 10  alpha olefins producing said porous propylene (co)polymer.
Patent EP-3041793-A1 (EP)
Inventor: NICOLAS SERGE
IPC: C01B39/24
Filed: 2014-08-06
Abstract: The present invention concerns Y-type FAU zeolites with hierarchical porosity having an Si/AI atomic ratio strictly greater than 1.4 and less than or equal to 6, having controlled and optimised crystallinity, and having mesoporosity such that the mesoporous outer surface area is between 40 m2. g-1 and 400 m2. g-1. The present invention also concerns the method for preparing said Y-type FAU zeolites with hierarchical porosity.
Patent EP-3058745-A1 (EP)
Inventor: RAMASUBRAMONIAN ADARSH KRISHNAN
IPC: H04N19/46
Filed: 2014-10-14
Abstract: An apparatus configured to code video information includes a memory unit and a processor in communication with the memory unit. The memory unit is configured to store video information associated with a video layer having a picture. The processor is configured to determine whether the picture is a non-picture-order-count (POC)-anchor picture, and based on the determination of whether the picture is a non-POC-anchor picture, perform one of (1) refraining from indicating a POC reset in connection with the picture, or (2) indicating the POC reset in connection with the picture. The processor may encode or decode the video information.
Patent EP-3072371-A1 (EP)
Title: Trägersubstrat für einen thermoelektrischen generator und elektrische schaltung
Inventor: PIRK TJALF
IPC: H01L35/30
Filed: 2014-11-03
Abstract: Die Erfindung betrifft ein Trägersubstrat (102) für ein Bauelement, insbesondere einen thermoelektrischen Generator (104), wobei das Trägersubstrat (102) eine Wärmeschnittstelle (106), eine Wärmetauscherstruktur (108) und einen Wärmeleiter (110) aufweist. Die Wärmeschnittstelle (106) ist dazu ausgebildet, den thermoelektrischen Generator (104) thermisch zu kontaktieren. Die Wärmetauscherstruktur (108) ist dazu ausgebildet, thermische Energie abzugeben und/oder aufzunehmen. Die Wärmetauscherstruktur (108) ist zumindest teilweise auf einer, der Wärmeschnittstelle (106) gegenüberliegenden Seite des Trägersubstrats (102) angeordnet. Der Wärmeleiter (110) ist dazu ausgebildet, die thermische Energie zwischen der Wärmeschnittstelle (106) und der Wärmetauscherstruktur (108) zu leiten.
Patent EP-2995961-A1 (EP)
Inventor: KATSUMOTO YOICHI
IPC: G01N37/00
Filed: 2014-04-14
Abstract: [Solving Means] A flow channel device includes a vessel layer and a flow channel layer. The vessel layer includes an injection vessel section into which a fluid including a sample is injected and a collection vessel section that collects the fluid. The flow channel layer includes a flow channel connected to the injection vessel section and the collection vessel section and is bonded to the vessel layer.
Patent EP-3066174-A1 (EP)
Inventor: MAYADE SABINE
IPC: B42D25/00
Filed: 2014-11-06
Abstract: Disclosed is a substrate which has thereon a marking or layer comprising a cured chiral liquid crystal precursor composition which does not contain any salt that would change the position of a selective reflection band exhibited by the cured composition.A modifying resin made from one or more polymerizable monomers comprising an average of at least one ether functionali typer polymerizable group is disposed between the substrate and the marking or layer and in contact with the marking or layer in one or more areas thereof. The modifying resin changes the position of a selective reflection band exhibited by the cured chiral liquid crystal precursor composition on the substrate in the one or more areas.
Patent EP-3062848-A1 (EP)
Inventor: DE BEER ISODORIS ANGELINUS QUIRINUS MARIA
IPC: A61M5/34
Filed: 2014-10-28
Abstract: Needle hub assembly (200) for a syringe (100), said assembly having a longitudinal axis (L1) comprising: - a needle hub body (210) having a syringe connector (212) for receiving an attachment member (110) of a syringe (100) at a first end (210a) of the body (210) and a needle receiving portion (214) at a second opposing end (210b) of the body (210), - a needle (216) extending from the needle receiving portion (214), wherein the syringe connector (212) comprises a substantially conical receiving opening (218) for receiving a syringe attachment member (110), at least a distal end (110b) thereof, wherein a length (A) of said opening (218), measured along the longitudinal axis (L1), is approximately 6.1+0.05mm.
Patent EP-3084861-A1 (EP)
Title: Vorrichtung zur erhöhung der sicherheit beim gebrauch von batteriesystemen
Inventor: FRIEDRICH MARCO
IPC: H01M10/42
Filed: 2014-11-18
Abstract: Die Erfindung geht aus von einem Batteriesystem (B), insbesondere einem Lithium-Ionen-Batteriesystem, mit mindestens einem Terminal (B) zur elektrischen Kontaktierung des Batteriesystems (B) mit einem anderen System und mit mindestens einem Aktor (A) zur Erhöhung der Sicherheit beim Gebrauch eines Batteriesystems (B), wobei der Aktor (A) zur Entladung des Batteriesystems (B) durch Herstellen eines elektrischen Kontaktes zwischen dem mindestens einen Terminal (T) und einem Gehäuse (G) des Batteriesystems (B) mittels eines Kontaktierungselementes (KE) geeignet ist, und wobei der Aktor (A) in das mindestens eine Terminal (T) zur elektrischen Kontaktierung eingefügt ist.
Patent EP-3063957-A1 (EP)
Inventor: SUNDSTEDT BO
IPC: H04W4/70
Filed: 2014-10-31
Abstract: A network node communicates with a radio access node that communicates application traffic on behalf of machine-to-machme (M2M) devices via a satellite link. The network node comprises a database and a control unit;. The database stores a plurality of recovery modes. Each recovery mode indicates one or more types of application traffic that M2M devices arc or are not allowed to transmit when operating according to that recovery mode. The control unit detects a loss of communication across, or congestion on, the satellite link, selects one of the recovery modes, and requests the radio access node to broadcast the selected recovery mode over a 3GPP- based broadcast channel in order to instruct the M2M devices to transmit only application traffic allowed in accordance with the selected recovery mode.
Patent EP-3085015-A1 (EP)
Inventor: LALAM MASSINISSA
IPC: H04L45/28
Filed: 2014-12-12
Abstract: In a communication network in the form of a tree of node devices and in which collisions of messages may occur, node devices may be relays between a concentrator device which is root of the tree and other node devices which are respectively attached to them, the node devices which are not relays being terminal node devices. The node devices implementing a monitoring mechanism in which the concentrator device despatches to the devices requests for verification of presence to which said node devices must respond before expiry of a predetermined timeout so as to notify of their presence in the communication network on pain of being considered to be disconnected from the communication network. The monitoring mechanism is deactivated (306) for certain at least of the relay node devices, and is activated (305) for the other node devices of the communication network. When at least all the terminal node devices attached directly or indirectly to a relay node device are considered disconnected by the monitoring mechanism, said relay node is considered to be disconnected from the communication network.
Patent EP-3056009-A1 (EP)
Inventor: CONDRA STEVEN CHARLES
IPC: H04N21/2385
Filed: 2014-10-07
Abstract: Reverse segmentation may be provided. First, a plurality of legs may be received and combined into a first service group. Next, it may be determined that a number of active user devices increased on at least one of the plurality of legs. A portion of the plurality of legs may then be switched from the first service group to a second service group in response to determining that the number of active user devices increased on the at least one of the plurality of legs.